9‐Methylfascaplysin Prevents Neuroinflammation and Synaptic Damage via Cell‐Specific Inhibition of Kinases in APP / PS1 Transgenic Mice
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.70100 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Jingyang Le und 19 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Center of Pain, Emotion and Cognition, Health Science Center, Ningbo University, Zhejiang, China. Hauptthemen laut MEDLINE: Mice, Transgenic, Amyloid beta-Protein Precursor, Neuroinflammatory Diseases, Presenilin-1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Research Project on Nonprofit Technology of Zhejiang Province, Ningbo Top Medical and Health Research Program, K. C. Wong Magna Fund in Ningbo University.
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) is a leading neurodegenerative disorder without effective treatments. The nonlinear dynamic nature of AD pathophysiology suggested that multiple pharmacological actions of anti‐AD drugs should be elucidated. 9‐Methylfascaplysin (9‐MF) was previously designed and synthesized as a novel anti‐AD candidate. Methods and Results In this study, 9‐MF at low concentrations significantly prevented cognitive impairments with similar efficacy as donepezil in APP/PS1 transgenic mice. In addition, 9‐MF potently reduced β‐amyloid (Aβ)‐associated neuroinflammation and tau‐associated synaptic damage in vivo. 9‐MF‐regulated microglia‐specific differentially phosphorylated proteins (DPPs) were mainly enriched in neuroinflammation, while 9‐MF‐regulated neuron‐specific DPPs were enriched in synaptic regulation, as revealed by a quantitative phosphoproteomic approach. A phosphoproteome‐kinome algorithm further identified that rho‐associated coiled‐coil kinase 2 (ROCK2) and glycogen synthase kinase 3β (GSK3β) ranked high in 9‐MF‐downregulated kinase perturbations. 9‐MF possessed high affinities for ROCK2 and GSK3β, which was confirmed by in vitro kinase activity assay. The protective effects of 9‐MF were abolished by ROCK2 knockdown in Aβ‐treated BV2 microglial cells, and by GSK3β knockdown in glyceraldehyde‐treated SH‐SY5Y neuronal cells, respectively.
Conclusions
All these results supported that 9‐MF produced anti‐AD effects via cell‐specific inhibition of ROCK2 and GSK3β in microglia and neurons, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Medicine Center of Pain, Emotion and Cognition, Health Science Center, Ningbo University, Zhejiang, China.
- Key Laboratory of Advanced Mass Spectrometry and Molecular Analysis of Zhejiang Province, School of Materials Science and Chemical Engineering, Ningbo University, Zhejiang, China.
- College of Food and Pharmaceutical Sciences, Ningbo University, Zhejiang, China.
- College of Biotechnology, Tianjin University of Science & Technology; Key Laboratory of Industrial Fermentation Microbiology, Ministry of Education, Tianjin Key Laboratory of Industrial Microbiology, Tianjin, China.
- School Infirmary, Ningbo University, Zhejiang, China.
- Department of Science and Conservation, San Diego Botanic Garden, California, USA.
Förderung
- Applied Research Project on Nonprofit Technology of Zhejiang Province
- Ningbo Top Medical and Health Research Program
- K. C. Wong Magna Fund in Ningbo University
- Applied Research Project on Nonprofit Technology of Ningbo
- One Health Interdisciplinary Research Project in Ningbo University
- LiDakSum Marine Biopharmaceutical Development Fund
- Ningbo Science and Technology Development Special Fund
- National Natural Science Foundation of China
Zitieren
APA
Le, J., Xia, C., Xu, J., Cai, J., Hu, C., Bai, Y., Chen, H., Rong, W., Jiang, Y., Wu, X., Li, Y., Wang, Q., Naman, C. B., Wei, H., Zhang, J., Liu, H., Chen, X., Liu, F., Liang, H., & Cui, W. (2024). 9‐Methylfascaplysin Prevents Neuroinflammation and Synaptic Damage via Cell‐Specific Inhibition of Kinases in APP / PS1 Transgenic Mice. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70100
Vancouver
Le J, Xia C, Xu J, Cai J, Hu C, Bai Y, et al. 9‐Methylfascaplysin Prevents Neuroinflammation and Synaptic Damage via Cell‐Specific Inhibition of Kinases in APP / PS1 Transgenic Mice. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70100
BibTeX
@article{Le2024,
author = {Le, Jingyang and Xia, Chenglong and Xu, Jiayi and Cai, Jinhan and Hu, Chenwei and Bai, Yu and Chen, Huiyue and Rong, Wenni and Jiang, Yujie and Wu, Xinming and Li, Yongmei and Wang, Qiyao and Naman, C Benjamin and Wei, Hua and Zhang, Jili and Liu, Hao and Chen, Xiaowei and Liu, Fufeng and Liang, Hongze and Cui, Wei},
title = {9‐Methylfascaplysin Prevents Neuroinflammation and Synaptic Damage via Cell‐Specific Inhibition of Kinases in APP / PS1 Transgenic Mice},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.70100}
}
EUVIMED